4/A//SEC Filing
Miller Joseph M 4/A
Accession 0001600620-24-000014
CIK 0001600620other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:17 PM ET
Size
5.0 KB
Accession
0001600620-24-000014
Insider Transaction Report
Form 4/AAmended
Miller Joseph M
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-03-02$8.78/sh−11,398$100,074→ 331,112 total
Footnotes (1)
- [F1]Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001746372
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:17 PM ET
- Size
- 5.0 KB